{"id":20865,"date":"2025-04-01T16:43:31","date_gmt":"2025-04-01T09:43:31","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=20865"},"modified":"2025-04-01T16:43:31","modified_gmt":"2025-04-01T09:43:31","slug":"shl-medical-opens-new-us220-million-manufacturing-facility-in-the-us-to-serve-growing-autoinjector-market","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=20865","title":{"rendered":"SHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market"},"content":{"rendered":"

ZUG, Switzerland<\/span><\/span>, April 1, 2025<\/span><\/span> \/PRNewswire\/ — SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-of-the-art manufacturing facility in North Charleston, South Carolina<\/span>. This strategic expansion marks a significant milestone in the Swiss-based company’s global growth, reinforcing its commitment to meeting the increasing worldwide demand for autoinjectors, most notably used in the cardiometabolic sector.<\/p>\n

\"The<\/a>
The new site in North Charleston, SC, is a key milestone in SHL Medical’s global expansion strategy, creating hundreds of local jobs.<\/span> <\/div>\n

The new facility will manufacture SHL Medical’s industry-leading autoinjectors, which are used in some of the world’s best-selling medications in areas such as endocrine and metabolic disorders (including GLP-1 therapies), dermatology, musculoskeletal diseases, and other therapy areas. It ensures a reliable supply of these critical devices to millions of patients worldwide. \u00a0<\/p>\n

Strengthening production capacity and US market presence<\/b><\/p>\n

SHL Medical is significantly increasing its production capacity to meet growing demand in North America<\/span> while strengthening supply chain resilience. “US-based production is a major step forward in our global expansion and reinforces our position as the leader in providing end-to-end drug delivery solutions,” said Ulrich Faessler<\/span>, CEO & Chairman of SHL Medical. “With our established site in Taiwan<\/span> and the upcoming facility in Switzerland<\/span>, we will be the only autoinjector manufacturer operating across three continents, bringing us even closer to our customers.”<\/p>\n

The fully automatized 360,000 ft\u00b2facility represents a US$220 million<\/span> investment and has already created over 300 local jobs, contributing to the economic growth of the region. Equipped with cutting-edge medical device injection molding technology and fully automated assembly capabilities, the site ensures unmatched precision, efficiency, and quality in SHL Medical’s advanced drug delivery solutions.<\/p>\n

By leveraging its existing final assembly, labeling, and packaging operations in Deerfield Beach, Florida<\/span>, and integrating recent acquisitions under SHL Advantec, the North Charleston<\/span> facility enhances SHL Medical’s US presence and solidifies its leadership in large-scale autoinjector production. The company is on track to deliver 1.5 billion devices to customers in 2025.<\/p>\n

“The most trusted autoinjector brand is now made in the USA<\/span>. We are proud to be contributing to the growth of the local economy and becoming a key player in the area while contributing to our sustainability goals.” adds Kimberlee Steele<\/span>, Managing Director North America at SHL Medical.<\/p>\n

The Grand Opening event, attended by approximately 180 guests, including South Carolina’s<\/span> Governor Henry McMaster<\/span> and Swiss Embassy Consul General Urs Broennimann<\/span>, marked the official opening of SHL Medical’s innovative autoinjector production in the United States<\/span>.<\/p>\n

For more detailed information about SHL’s latest expansion strategy, please refer to the press releases below:<\/p>\n

New manufacturing site in Zug, Switzerland<\/span><\/a><\/p>\n

New manufacturing site in North Charleston<\/span>, NC, USA<\/a><\/p>\n

SHL Medical announces plans to establish SHL Advantec<\/a><\/p>\n

SHL Medical acquires Swiss toolmaking company SMC Mould Innovation<\/a><\/p>\n

SHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.<\/a><\/p>\n

SHL Medical acquires 100% of the shares in Swiss company LCA Automation<\/a><\/p>\n

About SHL Medical<\/b><\/p>\n

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our core purpose of “enabling patients’ independence”, we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions enhance patients’ treatment experience and quality of life. With over 5,000 employees located across our offices in Switzerland<\/span>, USA<\/span>, Sweden<\/span>, and Taiwan<\/span>, we rely on our comprehensive in-house manufacturing capabilities to provide end-to-end services, from design, development, to final assembly, labeling, and packaging. For additional information, visit www.shl-medical.com<\/a><\/p>\n

Global Media Contact<\/b><\/p>\n

Burson Switzerland
shl-pressoffice@bcw-global.com<\/a><\/p>\n

\u00a0<\/p>","protected":false},"excerpt":{"rendered":"

<\/p>\n

ZUG, Switzerland<\/span><\/span>, April 1, 2025<\/span><\/span> \/PRNewswire\/ — SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-of-the-art manufacturing facility in North Charleston, South Carolina<\/span>. This strategic expansion marks a significant milestone in the Swiss-based company’s global growth, reinforcing its commitment to meeting the increasing worldwide demand for autoinjectors, most notably used in the cardiometabolic sector.<\/p>\n

\"The<\/a>
The new site in North Charleston, SC, is a key milestone in SHL Medical’s global expansion strategy, creating hundreds of local jobs.<\/span> <\/div>\n

The new facility will manufacture SHL Medical’s industry-leading autoinjectors, which are used in some of the world’s best-selling medications in areas such as endocrine and metabolic disorders (including GLP-1 therapies), dermatology, musculoskeletal diseases, and other therapy areas. It ensures a reliable supply of these critical devices to millions of patients worldwide. \u00a0<\/p>\n

Strengthening production capacity and US market presence<\/b><\/p>\n

SHL Medical is significantly increasing its production capacity to meet growing demand in North America<\/span> while strengthening supply chain resilience. “US-based production is a major step forward in our global expansion and reinforces our position as the leader in providing end-to-end drug delivery solutions,” said Ulrich Faessler<\/span>, CEO & Chairman of SHL Medical. “With our established site in Taiwan<\/span> and the upcoming facility in Switzerland<\/span>, we will be the only autoinjector manufacturer operating across three continents, bringing us even closer to our customers.”<\/p>\n

The fully automatized 360,000 ft\u00b2facility represents a US$220 million<\/span> investment and has already created over 300 local jobs, contributing to the economic growth of the region. Equipped with cutting-edge medical device injection molding technology and fully automated assembly capabilities, the site ensures unmatched precision, efficiency, and quality in SHL Medical’s advanced drug delivery solutions.<\/p>\n

By leveraging its existing final assembly, labeling, and packaging operations in Deerfield Beach, Florida<\/span>, and integrating recent acquisitions under SHL Advantec, the North Charleston<\/span> facility enhances SHL Medical’s US presence and solidifies its leadership in large-scale autoinjector production. The company is on track to deliver 1.5 billion devices to customers in 2025.<\/p>\n

“The most trusted autoinjector brand is now made in the USA<\/span>. We are proud to be contributing to the growth of the local economy and becoming a key player in the area while contributing to our sustainability goals.” adds Kimberlee Steele<\/span>, Managing Director North America at SHL Medical.<\/p>\n

The Grand Opening event, attended by approximately 180 guests, including South Carolina’s<\/span> Governor Henry McMaster<\/span> and Swiss Embassy Consul General Urs Broennimann<\/span>, marked the official opening of SHL Medical’s innovative autoinjector production in the United States<\/span>.<\/p>\n

For more detailed information about SHL’s latest expansion strategy, please refer to the press releases below:<\/p>\n

New manufacturing site in Zug, Switzerland<\/span><\/a><\/p>\n

New manufacturing site in North Charleston<\/span>, NC, USA<\/a><\/p>\n

SHL Medical announces plans to establish SHL Advantec<\/a><\/p>\n

SHL Medical acquires Swiss toolmaking company SMC Mould Innovation<\/a><\/p>\n

SHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.<\/a><\/p>\n

SHL Medical acquires 100% of the shares in Swiss company LCA Automation<\/a><\/p>\n

About SHL Medical<\/b><\/p>\n

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our core purpose of “enabling patients’ independence”, we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions enhance patients’ treatment experience and quality of life. With over 5,000 employees located across our offices in Switzerland<\/span>, USA<\/span>, Sweden<\/span>, and Taiwan<\/span>, we rely on our comprehensive in-house manufacturing capabilities to provide end-to-end services, from design, development, to final assembly, labeling, and packaging. For additional information, visit www.shl-medical.com<\/a><\/p>\n

Global Media Contact<\/b><\/p>\n

Burson Switzerland
shl-pressoffice@bcw-global.com<\/a><\/p>\n

\u00a0<\/p>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-20865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/20865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20865"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/20865\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}